4 plus 7 band purchase price, multi-province linkage, the market pattern will be subverted!

the original title: 4 plus 7 with volume procurement price, multi-provincial linkage, the market pattern will be subverted!December 17, Shanghai Sunshine Procurement Platform released the results of the 4-7-band procurement, 25 varieties, 43 product rules of the winning price was finalizedcan see that compared with the pre-selected results published 10 days ago (December 7), the prices of the corresponding rules are the same, while some varieties have increased the winning price of 1 to 2 product rulesthe purchase of the band to 11 cities 60% to 70% of the purchase volume in exchange for the lowest price of the larger varieties of clinical use, the results show that it is a useful attemptOfficial figures show an average decline of 52 per cent, a maximum of 96 per cent, with only two imported original drugs winning bids and achieving price divesthe final publication of the list of the selected list of band procurement, it means that this time the industry has a deep impact on the 4 plus 7 band volume procurement, will soon enter the procurement stageAnd participate in this volume of procurement of products, regardless of whether or not the election, its nationwide price reduction has become a certaintyWith this, the pharmaceutical market pattern will be completely subvertedthe lowest price linkage some provinces and cities have been prepared
although according to the Shanghai Sunshine Pharmaceutical Procurement Network publicnotice, the specific implementation date of the selected price needs to be announced separately, but some provinces and cities have been prepared to link the lowest pricethe national linkage, is 4 plus 7 with the volume of procurement just put forward, the industry has begun to worry about the problem, based on this concern, many people think that in the bidding is a small market share of enterprises, more likely to be desperate, the chances of winning a greaterthe results, and it isAmong the selected products, only seven were selected, including: Flubiliofin, Inapuri, Fusimpli, Giffeini, O'Natpin, Entikawe, Malayan in apurina tabletsthe remaining 18 selected products, previously a smaller market share, such as Jiangsu Howson's methionate Imatinib tablets, HDM system data show that in 2016 its market share of nearly 13%, Novartis's original drug accounted for 83.87 percentAnd the "biggest winner" zhejiang Huahai selected six varieties, in addition to paroxetine share of 36%, the rest only a few percent, or even zeroalthough the national linkage is not a mandatory requirement, nor is it a requirement in every province or cityBut in fact, through the inter-regional procurement alliance internal price linkage, local collection center for the price of the network restrictions and other forms, this way has long been implemented in many places just a month ago, on November 22nd, the Sichuan Drug Mining Center had just adjusted the price of 111 anti-cancer drugs, a maximum drop of 51.4% According to the province's regulations, this adjustment to the lowest price of the target is made once a month and October 11, Shandong, Liaoning has just joined the Beijing-Tianjin-Hebei pharmaceutical procurement consortium, and earlier (September 13), Shandong Provincial Commission of Health and Planning in a new round of collection requirements has specifically mentioned that the price of the linked network products to the standard Beijing-Tianjin-Hebei before, Zhejiang, Jiangsu, Shanxi and other places have been purchased prices may not be higher than the provisions of other provinces, Shaanxi, Guangxi, Hunan and other places have also been clear, to the country's lowest three provinces or five provinces as the reference price, price limit therefore, analysts pointed out that the price depression does not exist, the price of the 4 plus 7 is likely to become a new target After the floor price is exposed, the unselected product is also likely to face further "kill price" payment standards will be a game-changer is the purpose of of course, the price reduction is not the purpose of this volume procurement the day after the results of the pre-selection of the band procurement were announced, the National Health Insurance Administration had revealed that by crowding out the cost of drug sales, change the "with gold sales" model of purposes the results of the election officially announced, a Shanghai pharmaceutical centralized bidding procurement management issued a letter in the industry According to the document, based on different procurement models, without quantity, different prepaid models, it is recommended not to link the winning price of 4 plus 7 reference Shanghai on November 21 issued the "4 plus 7 city drug centralized procurement Shanghai area supplementary document", in addition to the amount, the only winning bid, with the amount of procurement and a series of supporting measures, such as: exclusive distribution; these measures, to ensure that the price of products, the enterprise's products according to the amount of good, the price of smooth access to the hospital, without having to experience "secondary bargaining", or even through "with gold sales" and other means to ensure sales; in the absence of supporting safeguards, direct linkage of the lowest price may be difficult to achieve the reform objectives As far as the purchase of the 4-plus-7 band is concerned, according to CCTV, the health insurance department will also issue more rules on medical insurance payments, hospital use, including: medical insurance payment standards, and to promote the use of selected drugs by medical personnel analysts believe that the impact of volume procurement to the industry is extremely far-reaching, in the long run, focus on innovation, product quality enterprises will usher in real benefits, the overall level of the pharmaceutical industry will also improve, but in the short term the necessary pain, sacrifice is inevitable source: Pharmaceutical Youhui Pharmaceutical Ring Copyright Notice: This article is transferred from China Medical Insurance, if you do not wish to be reproduced by the media or individuals can contact us, we will immediately delete the